Biotechnology Value Fund L P - Jun 30, 2025 SCHEDULE 13G/A Report for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

Filing Manager
Biotechnology Value Fund L P
Reporting Manager
BVF PARTNERS L P/IL
Security
CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol
CTMX
Shares outstanding
170M shares
Disclosed Ownership
11.5M shares
Ownership
6.8%
Form type
SCHEDULE 13G/A
Date filed
7/9/2025, 07:53 PM
Date of event
Jun 30, 2025
Next filing
Jul 9, 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 3.8% 6.15M 0 6.15M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 3.8% 6.15M 0 6.15M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 2.9% 4.7M 0 4.7M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 2.9% 4.7M 0 4.7M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.3% 541K 0 541K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.3% 541K 0 541K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 6.4% 10.9M 0 10.9M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 6.8% 11.5M 0 11.5M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 6.8% 11.5M 0 11.5M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 6.8% 11.5M 0 11.5M /s/ Mark N. Lampert Mark N. Lampert